Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Forbes today released the 2021 Midas List, a ranking of the world's top 100 venture capitalists. Duane Kuang and Nisa Leung, Managing Partners of...
Qiming Venture Partners' portfolio company Zhihu (NYSE: ZH) on March 26th EST listed on the New York Stock Exchange. The issue price is US$9.5/ADS....
Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price is US$ 17.00/ADS. ...
Qiming's portfolio company New Horizon Health (SEHK:6606) officially listed on the Main Board of Hong Kong Stock Exchange (HKEx) today. This is the...
Qiming Venture Partners ("Qiming") today announced the final close of our RMB Fund VI at RMB 2.852 billion. Currently, Qiming has $5.9 billion in...
Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the...
Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue...
Qiming Venture Partners today announced the final closing of Qiming Venture Partners Fund VII, a $1.2 billion fund focuses on early-stage Healthcare...
Qiming's portfolio company Zai Lab (SEHK:9688, NASDAQ:ZLAB), an innovative commercial-stage biopharmaceutical company, officially listed on the Main...
Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The...
Chinese biologic drug developer SinocellTech, Qiming's portfolio company, today lands on the Science and Technology Innovation Board (the STAR...
Forbes today released the 2020 Midas List, a ranking of the world's top 100 venture capitalists. Nisa Leung and Duane Kuang, Managing Partners of...
Qiming Venture Partners today announced the closing of Qiming Venture Partners Fund VII, a new $1.1B fund focused on early stage Healthcare and TMT...
Since the outbreak of the novel coronavirus (COVID-19) first emerged in January, Qiming Venture Partners' portfolio companies have been actively...
Qiming Venture Partners ("Qiming") would like to congratulate Xiaomi Corp (HKSE: 1810) on its successful IPO on the Hong Kong Stock Exchange on July...
Qiming Venture Partners ("Qiming", www.qimingvc.com), a leading venture capital firm in China, today announced the successful closing of three new...
Qiming Venture Partners ("Qiming"), a leading venture capital firm in China, today, announced the addition of Steven Hu, as a partner focused on...
On November 4, Qiming Venture Partners held the 2016 Annual Limited Partners Meeting, the 8th CEO Summit and the 10th Anniversary Celebration...
Qiming Venture Partners ("Qiming"), a leading venture capital firm in China, today, announced the successful closing of Fund V, its fifth US Dollar...
The healthcare market is one valued in the trillions of Chinese yuan. Compared with other industries, starting a business in the healthcare industry...
Qiming Venture Partners ("Qiming"), a leading venture capital firm in China, today, announced the promotion of Peter YIN Ming (Cleantech), Stella...
Qiming Venture Partners, today announces the promotion of William Hu to Managing Partner effective immediately. William has been with Qiming for...
Qiming Venture Partners announced today that it had closed Fund IV at $500 million. This fund continues Qiming's strategy of funding innovations...
Qiming Venture Partners ("Qiming"), a leading venture capital firm in China, today announced the addition of Helen Wong as a partner focused on...
Sangon Biotech, a Shanghai based life science research service company, and Bio Basic Inc. (BBI), a Toronto based life science research service...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.